ViaCell Report issue

For profit Phase 1
Founded: Boston MA United States (1993)
Status: Acquired by Perkin Elmer Inc. (2007)

Organization Overview

First Clinical Trial
2007
NCT00498316
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Preleukemia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 11